109 related articles for article (PubMed ID: 19946023)
1. The immunoregulatory role of vitamins A, D and E in patients with primary Sjogren's syndrome.
Szodoray P; Horvath IF; Papp G; Barath S; Gyimesi E; Csathy L; Kappelmayer J; Sipka S; Duttaroy AK; Nakken B; Zeher M
Rheumatology (Oxford); 2010 Feb; 49(2):211-7. PubMed ID: 19946023
[TBL] [Abstract][Full Text] [Related]
2. Immunological alterations in newly diagnosed primary Sjögren's syndrome characterized by skewed peripheral T-cell subsets and inflammatory cytokines.
Szodoray P; Gal I; Barath S; Aleksza M; Horvath IF; Gergely P; Szegedi G; Nakken B; Zeher M
Scand J Rheumatol; 2008; 37(3):205-12. PubMed ID: 18465456
[TBL] [Abstract][Full Text] [Related]
3. Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome.
van Woerkom JM; Kruize AA; Wenting-van Wijk MJ; Knol E; Bihari IC; Jacobs JW; Bijlsma JW; Lafeber FP; van Roon JA
Ann Rheum Dis; 2005 Oct; 64(10):1474-9. PubMed ID: 15817659
[TBL] [Abstract][Full Text] [Related]
4. Circulating levels of Th1/Th2 cytokines in patients with primary Sjögren's syndrome: correlation with clinical and immunological features.
Garcíc-Carrasco M; Font J; Filella X; Cervera R; Ramos-Casals M; Sisó A; Aymamí A; Ballesta AM; Ingelmo M
Clin Exp Rheumatol; 2001; 19(4):411-5. PubMed ID: 11491496
[TBL] [Abstract][Full Text] [Related]
5. Th2 cytokine genotypes are associated with a milder form of primary Sjogren's syndrome.
Pertovaara M; Antonen J; Hurme M
Ann Rheum Dis; 2006 May; 65(5):666-70. PubMed ID: 16166103
[TBL] [Abstract][Full Text] [Related]
6. Th1 predominance and perforin expression in minor salivary glands from patients with primary Sjögren's syndrome.
Kolkowski EC; Reth P; Pelusa F; Bosch J; Pujol-Borrell R; Coll J; Jaraquemada D
J Autoimmun; 1999 Aug; 13(1):155-62. PubMed ID: 10441181
[TBL] [Abstract][Full Text] [Related]
7. Characterization of peripheral natural killer cells in primary Sjögren's syndrome: impaired NK cell activity and low NK cell number.
Izumi Y; Ida H; Huang M; Iwanaga N; Tanaka F; Aratake K; Arima K; Tamai M; Kamachi M; Nakamura H; Origuchi T; Kawakami A; Anderson P; Eguchi K
J Lab Clin Med; 2006 May; 147(5):242-9. PubMed ID: 16697772
[TBL] [Abstract][Full Text] [Related]
8. [Preliminary study on the activity of natural killer cells in patients with Sjogren's syndrome].
Wang JM
Zhonghua Kou Qiang Yi Xue Za Zhi; 1988 Jul; 23(4):244-6. PubMed ID: 3234131
[No Abstract] [Full Text] [Related]
9. Polarization of B effector cells in Sjögren's syndrome.
Daridon C; Guerrier T; Devauchelle V; Saraux A; Pers JO; Youinou P
Autoimmun Rev; 2007 Aug; 6(7):427-31. PubMed ID: 17643928
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 2 augmentation of the defective natural killer cell activity in patients with primary Sjögren's syndrome.
Pedersen BK; Oxholm P; Manthorpe R; Andersen V
Clin Exp Immunol; 1986 Jan; 63(1):1-7. PubMed ID: 3485480
[TBL] [Abstract][Full Text] [Related]
11. Effect of vitamin A treatment on immune reactivity and lipid peroxidation in patients with Sjögren's syndrome.
Szöcsik K; González-Cabello R; Vien CV; Mézes M; Szongoth M; Gergely P
Clin Rheumatol; 1988 Dec; 7(4):514-9. PubMed ID: 3246135
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemical study of inflammatory infiltrates in minor salivary glands in Sjögren's syndrome and other autoimmune diseases].
Tomás S; Coll J; Reth P; Corominas JM
Med Clin (Barc); 1998 Nov; 111(18):681-6. PubMed ID: 9887430
[TBL] [Abstract][Full Text] [Related]
13. Elevated Th1/Th2 cell ratios in a pregnant woman with a history of RSA, secondary Sjögren's syndrome and rheumatoid arthritis complicated with one fetal demise of twin pregnancy.
Kwak-Kim J; Lee SK; Gilman-Sachs A
Am J Reprod Immunol; 2007 Oct; 58(4):325-9. PubMed ID: 17845202
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D and Sjögren syndrome.
Garcia-Carrasco M; Jiménez-Herrera EA; Gálvez-Romero JL; de Lara LV; Mendoza-Pinto C; Etchegaray-Morales I; Munguía-Realpozo P; Ruíz-Argüelles A; Jose R; Vera-Recabarren M; Cervera R
Autoimmun Rev; 2017 Jun; 16(6):587-593. PubMed ID: 28411165
[TBL] [Abstract][Full Text] [Related]
15. [Natural cytotoxicity in Sjögren's syndrome].
Aleksandrova EN; Nasonov EL; Vasil'ev VI; Bykhovskaia SIu; Zimin IuI
Ter Arkh; 1984; 56(7):103-6. PubMed ID: 6484820
[No Abstract] [Full Text] [Related]
16. Impaired release of natural killer cytotoxic factor in patients with primary Sjögren's syndrome.
Pedersen BK; Oxholm P
Clin Exp Immunol; 1988 May; 72(2):299-302. PubMed ID: 3409548
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the immune status in patients with primary and secondary Sjögren's syndrome.
Slezák R; Krejsek J; Kopecký O; Drízhal I
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(1):11-2. PubMed ID: 7569721
[TBL] [Abstract][Full Text] [Related]
18. [Studies on killer cells (K-cells) in peripheral blood in Sjögren's syndrome (author's transl)].
Ichikawa Y; Sasao K; Takaya M; Arimori S
Ryumachi; 1980 Sep; 20(4):253-9. PubMed ID: 7444663
[No Abstract] [Full Text] [Related]
19. [Cell-mediated immunity in patients with Sjogren's syndrome].
Krejsek J; Slezák R; Kopecký O; Vokurková D; Loudová M; Derner V
Cas Lek Cesk; 1997 Jan; 136(2):44-7. PubMed ID: 9147852
[TBL] [Abstract][Full Text] [Related]
20. [Expression of CD4+ CD25+ regulatory T cells in peripheral blood and salivary gland of patients with primary Sjögren's syndrome].
Li XM; Li XP; Qian L; Wang GS; Zhang H; Zhei ZM; Li Q; Chen K; Wang XQ; Wang YP
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1034-6. PubMed ID: 17672966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
